0001127602-21-010168.txt : 20210310 0001127602-21-010168.hdr.sgml : 20210310 20210310210152 ACCESSION NUMBER: 0001127602-21-010168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPA JOSEPH C CENTRAL INDEX KEY: 0001242215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 21731550 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS INC STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-03-08 0000885590 Bausch Health Companies Inc. BHC 0001242215 PAPA JOSEPH C 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 1 CHAIRMAN & CEO Common Shares, No Par Value 2021-03-08 4 M 0 317089 A 1162912 D Common Shares, No Par Value 2021-03-08 4 A 0 108254 0 A 1271166 D Common Shares, No Par Value 2021-03-10 4 F 0 231188 32.97 D 1039978 D Restricted Share Units 2021-03-08 4 M 0 317089 D 2021-03-07 Common Stock 317089 0 D Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Each PSU converts into Common Shares on a one-for-one basis. This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 511,434 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. /s/ Kirsten O'Donnell, attorney-in-fact for Joseph C. Papa 2021-03-10